Inventor · disambiguated record
Dolores Schendel
Also filed as: SCHENDEL DOLORES · SCHENDEL DOLORES J · SCHENDEL DOLORES JEAN
21 granted patents·11 pending applications·238 citations·filing 1996–2023
94Inventor score
Files withMEDIGENE IMMUNOTHERAPIES GMBH8SCHENDEL DOLORES4MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN3HELMHOLTZ ZENTRUM MUNCHEN DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT GMBH2HELMHOLTZ ZENTRUM MÜNCHEN-DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH)2
Top patents by PatentIndex Score
32 records- 0195US8697854B2High affinity T cell receptor and use thereofSCHENDEL DOLORES·Filed 2009·Granted Apr 15, 2014·120 cites·2 claims
- 0290US8486694B2Generation of antigen specific T cellsSCHENDEL DOLORES·Filed 2006·Granted Jul 16, 2013·20 cites·17 claims
- 0388US7731950B2Attack of tumor cells with missing, low or aberrant MHC expression by combining non MHC-restricted T-cells/NK-cells and MHC-restricted cellsHELMHOLTZ ZENTRUM MUNCHEN DEUT·Filed 2002·Granted Jun 8, 2010·53 cites·3 claims
- 0486US10882891B2Dendritic cell compositionMEDIGENE IMMUNOTHERAPIES GMBH·Filed 2016·Granted Jan 5, 2021·4 cites·15 claims
- 0586US9862755B2High affinity T cell receptor and use thereofMAX-DELBRUECK-CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2014·Granted Jan 9, 2018·5 cites·4 claims
- 0684US11292838B2Method for generating antibodies against T cell receptorMEDIGENE IMMUNOTHERAPIES GMBH·Filed 2016·Granted Apr 5, 2022·6 cites·17 claims
- 0781US10626159B2High affinity T cell receptor and use thereofMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2017·Granted Apr 21, 2020·1 cites·6 claims
- 0879US9409969B2Repertoire of allo-restricted peptide-specific T cell receptor sequences and use thereofSCHENDEL DOLORES J·Filed 2010·Granted Aug 9, 2016·6 cites·13 claims
- 0975US8206701B2Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cellsSCHENDEL DOLORES·Filed 2003·Granted Jun 26, 2012·6 cites·4 claims
- 1069US2024083967A1T cell receptors and uses thereofMEDIGENE IMMUNOTHERAPIES GMBH·Filed 2023·Application pending·0 cites
- 1165US12215313B2Method of detecting new immunogenic T cell epitopes and isolating new antigen-specific T cell receptors by means of an MHC cell libraryMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2021·Granted Feb 4, 2025·0 cites·8 claims
- 1265US2020339653A1High affinity t cell receptor and use thereofMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2020·Application pending·0 cites
- 1360US9597384B2Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cellsHELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH)·Filed 2015·Granted Mar 21, 2017·0 cites·14 claims
- 1459US8142772B2Attack of tumor cells with missing, low or aberrant MHC expression by combining non MHC-restricted T-cells/NK-cells and MHC-restricted cellsNOESSNER ELFRIEDE·Filed 2010·Granted Mar 27, 2012·1 cites·20 claims
- 1559US7064190B1Antigen-specific, activated T lymphocytes, detection and useROCHE DIAGNOSTICS GMBH·Filed 1999·Granted Jun 20, 2006·15 cites·17 claims
- 1658US11732020B2T cell receptors and uses thereofMEDIGENE IMMUNOTHERAPIES GMBH·Filed 2017·Granted Aug 22, 2023·0 cites·13 claims
- 1758US9238063B2Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cellsSCHENDEL DOLORES·Filed 2011·Granted Jan 19, 2016·0 cites·9 claims
- 1856US9512402B2Compositions for the preparation of mature dendritic cellsHELMHOLTZ ZENTRUM MUNCHEN DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH)·Filed 2014·Granted Dec 6, 2016·0 cites·18 claims
- 1955US11155589B2Generation of antigen-specific TCRsMEDIGENE IMMUNOTHERAPIES GMBH·Filed 2016·Granted Oct 26, 2021·0 cites·20 claims
- 2055US9504692B2Selective inhibition of MALT1 protease by phenothiazine derivativesKRAPPMANN DANIEL·Filed 2012·Granted Nov 29, 2016·1 cites·21 claims
- 2152US8679840B2Compositions for the preparation of mature dendritic cellsSCHENDEL DOLORES J·Filed 2007·Granted Mar 25, 2014·0 cites·18 claims
- 2251US11001830B2Method of detecting new immunogenic T cell epitopes and isolating new antigen-specific T cell receptors by means of an MHC cell libraryMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2016·Granted May 11, 2021·0 cites·7 claims
- 2349US2006171954A1Antigen specific activated T-lymphocytes, detection and useROCHE DIAGNOSTICS GMBH·Filed 2006·Application pending·0 cites
- 2448US2017037372A1Compositions for the preparation of mature dendritic cellsHELMHOLTZ ZENTRUM MUNCHEN DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH)·Filed 2016·Application pending·0 cites
- 2548US2014141026A1Generation of antigen specific t cellsHELMHOLTZ ZENTRUM MUENCHEN·Filed 2013·Application pending·0 cites
- 2648US2011020308A1Expression of transgenic t cell receptors in lak-t cellsSCHENDEL DOLORES JEAN·Filed 2007·Application pending·0 cites
- 2746US2021063413A1Dendritic cell potency assayMEDIGENE IMMUNOTHERAPIES GMBH·Filed 2017·Application pending·0 cites
- 2843US2017044233A1Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereofHelmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)·Filed 2016·Application pending·0 cites
- 2939US10858760B2T cell receptor libraryMEDIGENE IMMUNOTHERAPIES GMBH·Filed 2016·Granted Dec 8, 2020·0 cites·17 claims
- 3037US2018256716A1T-cell receptor specific antibodiesMEDIGENE IMMUNOTHERAPIES GMBH·Filed 2016·Application pending·0 cites
- 3129US2002045241A1T cells specific for kidney carcinomaFiled 1997·Application pending·0 cites
- 3225US2002114816A1Autoreactive peptides from human glutamic acid-decarboxylase (gad)Filed 1996·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →